According to the World Health Organisation, roughly half of all cancer deaths are due to late-stage diagnoses, highlighting the need for more effective early detection methods to best improve patient outcomes.
Elypta is a developing a new method for early cancer detection. Their approach involves analysing a substance called the GAGome in a urine or plasma sample and using machine learning to identify patterns that might indicate cancer.
According to the World Health Organisation, roughly half of all cancer deaths are due to late-stage diagnoses, highlighting the need for more effective early detection methods to best improve patient outcomes.
Elypta is a developing a new method for early cancer detection. Their approach involves analysing a substance called the GAGome in a urine or plasma sample and using machine learning to identify patterns that might indicate cancer.
Explore companies within the same category